GT199700058A - Virosomas cationicos como sistema de transferencia para material genetico. - Google Patents
Virosomas cationicos como sistema de transferencia para material genetico.Info
- Publication number
- GT199700058A GT199700058A GT199700058A GT199700058A GT199700058A GT 199700058 A GT199700058 A GT 199700058A GT 199700058 A GT199700058 A GT 199700058A GT 199700058 A GT199700058 A GT 199700058A GT 199700058 A GT199700058 A GT 199700058A
- Authority
- GT
- Guatemala
- Prior art keywords
- genetic material
- preparation
- cells
- transfer system
- virosomes
- Prior art date
Links
- 239000000277 virosome Substances 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96107282 | 1996-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT199700058A true GT199700058A (es) | 1998-10-29 |
Family
ID=8222763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199700058A GT199700058A (es) | 1996-05-08 | 1997-05-07 | Virosomas cationicos como sistema de transferencia para material genetico. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6210708B1 (online.php) |
| EP (1) | EP0902682A2 (online.php) |
| JP (1) | JP2000509404A (online.php) |
| KR (1) | KR100536983B1 (online.php) |
| CN (1) | CN1271992C (online.php) |
| AR (1) | AR007054A1 (online.php) |
| AU (1) | AU710170B2 (online.php) |
| BG (1) | BG102880A (online.php) |
| BR (1) | BR9709224A (online.php) |
| CA (1) | CA2253561A1 (online.php) |
| CO (1) | CO4600638A1 (online.php) |
| CZ (1) | CZ299809B6 (online.php) |
| EA (1) | EA003130B1 (online.php) |
| GT (1) | GT199700058A (online.php) |
| HR (1) | HRP970234B1 (online.php) |
| HU (1) | HUP9901790A3 (online.php) |
| ID (1) | ID17934A (online.php) |
| NO (1) | NO327726B1 (online.php) |
| NZ (1) | NZ332666A (online.php) |
| OA (1) | OA10916A (online.php) |
| PA (1) | PA8429201A1 (online.php) |
| PE (1) | PE65198A1 (online.php) |
| PL (1) | PL199201B1 (online.php) |
| SK (1) | SK152698A3 (online.php) |
| SV (1) | SV1997000032A (online.php) |
| TN (1) | TNSN97080A1 (online.php) |
| WO (1) | WO1997041834A1 (online.php) |
| ZA (1) | ZA973885B (online.php) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030113347A1 (en) * | 1991-05-08 | 2003-06-19 | Schweiz. Serum- & Impfinstitut Bern | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| AU9224398A (en) * | 1997-09-08 | 1999-03-29 | Promega Corporation | Method of (in vivo) transformation utilizing lipid vehicles |
| SE513149C2 (sv) * | 1997-12-05 | 2000-07-17 | Katarina Edwards | Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna |
| GB9813100D0 (en) * | 1998-06-18 | 1998-08-19 | Secr Defence | Method of forming liposomes |
| PL355231A1 (en) * | 1999-10-08 | 2004-04-05 | Nika Health Products Limited | Cationic dosper virosomes |
| ES2202218T3 (es) * | 1999-12-17 | 2004-04-01 | Schott Glas | Capsula fulminante activable inductivamente para sistemas de retencion de pasajeros y circuito de prueba para esta capsula fulminante. |
| US20030139361A1 (en) * | 2000-01-21 | 2003-07-24 | Kazuhiro Yuda | Drug for gene therapy |
| AU2002346084B2 (en) * | 2001-07-23 | 2006-11-16 | Onyx Pharmaceuticals, Inc. | Viral mutants that selectively replicate in targeted human cancer cells |
| KR100411234B1 (ko) * | 2001-08-14 | 2003-12-18 | 한국과학기술원 | 올리고뉴클레오티드 혼성화 미셀 및 그의 제조방법 |
| WO2003038103A1 (en) * | 2001-10-29 | 2003-05-08 | Atso Raasmaja | Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers |
| US20040028687A1 (en) * | 2002-01-15 | 2004-02-12 | Waelti Ernst Rudolf | Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues |
| US20040176283A1 (en) * | 2002-04-01 | 2004-09-09 | Robinson John A. | Methods and compositions for the design of synthetic vaccines |
| PL377161A1 (pl) * | 2002-11-21 | 2006-01-23 | Pevion Biotech Ltd. | Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki |
| US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| WO2005056752A2 (en) | 2003-10-24 | 2005-06-23 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
| US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
| US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
| US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
| US20090208478A1 (en) * | 2003-10-24 | 2009-08-20 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| DE102004057303A1 (de) * | 2004-11-26 | 2006-06-01 | Merck Patent Gmbh | Stabile Kristallmodifikationen von DOTAP Chlorid |
| US20070172520A1 (en) * | 2005-11-18 | 2007-07-26 | University Of South Florida | Immunotargeting of Nonionic Surfactant Vesicles |
| CN102026645B (zh) | 2006-09-15 | 2016-01-27 | 渥太华医院研究机构 | 溶瘤弹状病毒 |
| KR101242113B1 (ko) * | 2010-10-22 | 2013-03-19 | 고마바이오텍(주) | 유전자 전달용 양이온성 센다이 ｆ／ｈｎ 바이로좀 복합체 |
| WO2013032643A2 (en) * | 2011-08-31 | 2013-03-07 | Dicerna Pharmaceuticals, Inc. | Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
| ES2698076T3 (es) * | 2011-10-07 | 2019-01-30 | Isd Immunotech Aps | Identificación de los dominios inmunosupresores en las proteínas de fusión de los virus de ARN con envoltura |
| AU2017336199B2 (en) | 2016-09-27 | 2020-08-20 | Camurus Ab | Mixtures and formulations comprising an alkyl ammonium EDTA salt |
| CN109055432B (zh) * | 2018-08-16 | 2020-10-13 | 南京科佰生物科技有限公司 | 慢病毒感染试剂及其制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
| US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| PL296382A1 (en) * | 1991-02-02 | 1993-11-02 | Nika Health Products Ltd Li Li | Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system |
| AU655823B2 (en) * | 1991-05-08 | 1995-01-12 | Crucell Switzerland Ag | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| WO1993014744A1 (en) | 1992-02-04 | 1993-08-05 | Chiron Corporation | Non-toxic lipid vaccine formulations |
| US5631237A (en) | 1992-12-22 | 1997-05-20 | Dzau; Victor J. | Method for producing in vivo delivery of therapeutic agents via liposomes |
| US5578475A (en) * | 1993-07-12 | 1996-11-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
| EP0762870B1 (en) * | 1994-05-31 | 2002-09-11 | INEX Pharmaceutical Corp. | Virosome-mediated intracellular delivery of therapeutic agents |
| FR2726764B1 (fr) | 1994-11-14 | 1997-01-31 | Pasteur Merieux Serums Vacc | Adjuvant pour composition vaccinale |
-
1997
- 1997-05-04 AU AU27766/97A patent/AU710170B2/en not_active Ceased
- 1997-05-04 WO PCT/EP1997/002268 patent/WO1997041834A1/en not_active Ceased
- 1997-05-04 NZ NZ332666A patent/NZ332666A/xx unknown
- 1997-05-04 HU HU9901790A patent/HUP9901790A3/hu unknown
- 1997-05-04 CA CA002253561A patent/CA2253561A1/en not_active Abandoned
- 1997-05-04 CN CNB971962324A patent/CN1271992C/zh not_active Expired - Fee Related
- 1997-05-04 SK SK1526-98A patent/SK152698A3/sk unknown
- 1997-05-04 KR KR1019980708906A patent/KR100536983B1/ko not_active Expired - Fee Related
- 1997-05-04 CZ CZ0361498A patent/CZ299809B6/cs not_active IP Right Cessation
- 1997-05-04 JP JP9539526A patent/JP2000509404A/ja active Pending
- 1997-05-04 EP EP97921852A patent/EP0902682A2/en not_active Withdrawn
- 1997-05-04 BR BR9709224A patent/BR9709224A/pt unknown
- 1997-05-04 PL PL329853A patent/PL199201B1/pl not_active IP Right Cessation
- 1997-05-04 EA EA199800992A patent/EA003130B1/ru not_active IP Right Cessation
- 1997-05-06 ZA ZA973885A patent/ZA973885B/xx unknown
- 1997-05-07 TN TNTNSN97080A patent/TNSN97080A1/fr unknown
- 1997-05-07 GT GT199700058A patent/GT199700058A/es unknown
- 1997-05-07 SV SV1997000032A patent/SV1997000032A/es unknown
- 1997-05-07 CO CO97024481A patent/CO4600638A1/es unknown
- 1997-05-07 HR HR970234A patent/HRP970234B1/xx not_active IP Right Cessation
- 1997-05-07 PE PE1997000354A patent/PE65198A1/es not_active Application Discontinuation
- 1997-05-08 PA PA19978429201A patent/PA8429201A1/es unknown
- 1997-05-08 AR ARP970101917A patent/AR007054A1/es not_active Application Discontinuation
- 1997-05-09 ID IDP971533A patent/ID17934A/id unknown
-
1998
- 1998-10-29 BG BG102880A patent/BG102880A/xx unknown
- 1998-11-04 NO NO19985137A patent/NO327726B1/no not_active IP Right Cessation
- 1998-11-06 OA OA9800214A patent/OA10916A/en unknown
-
1999
- 1999-10-08 US US09/414,872 patent/US6210708B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8429201A1 (es) | Virosomas cationicos como sistema de transferencia para material genetico | |
| GT200100007A (es) | Antagonistas del factor liberador de corticotropina. | |
| DE69827127D1 (de) | Mehrwertige impstoffzusammensetzung mit gemischten trägern | |
| ES2070253T3 (es) | Ciclohexanoles sustituidos utiles como agentes para el sistema nervioso central. | |
| MX9403570A (es) | Conjugados de farmaco-ligando, proceso para su preparacion y composicionesfarmaceuticas que los incluyen. | |
| PE20000002A1 (es) | Conjugados de polimeros de proteina ligada a histidina sustancialmente puros | |
| PT2121731E (pt) | Vacinas peptídicas para cancros que expressam antigénios associados a tumores | |
| TR200201588T2 (tr) | Yeni bitki tanım yapıları | |
| BR0110610A (pt) | Anticorpos isolados, imunoconjugados, cadeias de polipeptìdeos, ácido nucléico isolado, vetor, célula hospedeira, processo de produção de anticorpo ou cadeia de polipeptìdeos, método de tratamento de disfunções em mamìferos, método de indução da apoptose de uma célula cancerosa, método para matar uma célula b, método para matar uma célula que expresse um receptor de erbb e usos dos anticorpos isolados | |
| FI963103A7 (fi) | Ei-virusvektori | |
| ES2010538A6 (es) | Procedimiento para la preparacion de un gen sintetico. | |
| DE69628290D1 (de) | Methoden und zusammensetzungen zur lipidisierung hydrophiler moleküle | |
| PA8583201A1 (es) | Nuevos compuestos de pirazol como inhibidores del factor de crecimiento transformante (tgf) | |
| SV1998000029A (es) | Compuestos de pirazina ref. pg3186 | |
| ES2181799T3 (es) | Conjugados de acidos peptido nucleicos. | |
| AR036272A1 (es) | Genes de metiltransferasas y usos de los mismos | |
| ES8202586A1 (es) | Un procedimiento para clonar una secuencia de desoxinucleo- tidos | |
| BR9901279A (pt) | Triciclicos substituìdos | |
| BR0010590A (pt) | Emprego de filanto para estimulação objetivada do sistema imunológico | |
| AR034542A1 (es) | Composiciones y metodo para la modificacion genetica de plantas | |
| BRPI0409046A (pt) | sistemas policetìdio sintase (pks) de ácido graxo poliinsaturado (pufa) e usos dos mesmos | |
| CR6683A (es) | Sistema de entrega de quelator de hierro | |
| AR026571A1 (es) | Genes del musgo de la physcomitrella patens que codifican proteinas que participan en la sintesis de los acidos grasos poliinsaturados y lipidos | |
| ES2067544T3 (es) | Membranas de afinidad que tienen grupos hidroxilo pendientes y procesos para la preparacion y uso de las mismas. | |
| AR011994A1 (es) | Secuencia aislada de acidos nucleicos, vector para la distribucion de dicha secuencia aislada de acidos nucleicos, celula huesped, planta y metodo |